iShares Genomics Immunology and Healthcare ETF Rating $20.69 +0.42 (+2.07%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy 2.74Holdings in IDNA have an aggregate rating of Moderate Buy based on 401 analyst ratings issued in the past year covering 38 companies (58.2% of the portfolio).IDNA Aggregate Price Target$20.69High Prediction$20.69Average Prediction$20.69Low Prediction$20.69Holdings in IDNA have an aggregate price target of $20.69 and a range of $20.69 to $20.69 covering 38 companies (58.2% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 38 IDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.04%EXELExelixis$37.21+1.2%4.2836 of 5 stars2.50$37.59 1.0%20Upcoming EarningsPositive News4.47%SWTXSpringWorks Therapeutics$44.93+9.0%2.397 of 5 stars3.00$73.20 62.9%5Upcoming EarningsNews CoveragePositive NewsHigh Trading Volume4.17%INCYIncyte$58.97+1.7%4.8409 of 5 stars2.21$74.69 26.7%19Upcoming EarningsAnalyst ForecastNews Coverage4.13%MRKMerck & Co., Inc.$79.93+1.5%5 of 5 stars2.59$111.13 39.0%22Earnings ReportAnalyst ForecastAnalyst RevisionPositive News3.85%REGNRegeneron Pharmaceuticals$599.76+2.0%4.8513 of 5 stars2.88$949.60 58.3%26Upcoming EarningsAnalyst ForecastAnalyst RevisionPositive News3.78%BNTXBioNTech$120.54+5.0%1.6662 of 5 stars2.89$143.44 19.0%18Analyst RevisionNews CoveragePositive News3.62%ACLXArcellx$63.97+0.5%1.9024 of 5 stars3.14$110.67 73.0%14News CoveragePositive News3.54%TWSTTwist Bioscience$40.17+6.8%3.6344 of 5 stars2.70$52.80 31.4%10Upcoming EarningsPositive News3.40%RVMDRevolution Medicines$38.58+3.0%3.8818 of 5 stars3.00$66.67 72.8%12Positive News2.95%MRNAModerna$27.39+3.2%4.3506 of 5 stars2.04$58.70 114.3%24Upcoming EarningsNews Coverage2.24%BCRXBioCryst Pharmaceuticals$8.22+3.3%4.1396 of 5 stars2.86$15.57 89.4%72.07%JANXJanux Therapeutics$32.07+1.4%2.6528 of 5 stars3.09$95.25 197.0%11Insider TradePositive News1.66%NVAXNovavax$7.07-5.4%3.6536 of 5 stars2.43$18.00 154.6%7News Coverage1.35%GERNGeron$1.42+2.2%3.8024 of 5 stars2.82$5.75 304.9%11Analyst Revision1.29%IOVAIovance Biotherapeutics$3.36+5.3%4.1866 of 5 stars2.89$18.22 442.3%9News Coverage0.99%XNCRXencor$10.84-0.3%3.3637 of 5 stars3.13$33.86 212.3%8Analyst ForecastAnalyst RevisionNews Coverage0.85%VIRVir Biotechnology$6.29+5.4%2.7713 of 5 stars2.86$33.57 433.7%7Upcoming EarningsNews CoveragePositive News0.81%ABCLAbCellera Biologics$2.60+2.8%2.4888 of 5 stars2.67$7.50 188.5%3News Coverage0.79%IBRXImmunityBio$2.691.895 of 5 stars3.00$12.19 353.1%5Analyst Forecast0.67%KURAKura Oncology$6.43+0.9%4.3188 of 5 stars2.92$25.50 296.6%12Upcoming EarningsNews CoveragePositive News0.57%RCUSArcus Biosciences$8.41+3.6%2.3056 of 5 stars3.00$28.38 237.6%10Analyst Forecast0.52%IMNMImmunome$8.52+0.2%2.5635 of 5 stars3.00$25.14 195.1%7Positive News0.52%RIGLRigel Pharmaceuticals$19.06+5.0%2.7379 of 5 stars2.40$36.80 93.1%5Positive News0.51%PACBPacific Biosciences of California$1.14-2.6%2.5291 of 5 stars2.50$2.45 114.9%100.47%MREOMereo BioPharma Group$2.54-0.8%1.8437 of 5 stars3.25$7.71 203.7%8News CoverageHigh Trading Volume0.46%CELCCelcuity$11.04-0.3%1.6179 of 5 stars3.14$30.17 173.2%70.40%VERVVerve Therapeutics$5.78+5.7%2.8907 of 5 stars3.00$25.75 345.5%60.39%ARCTArcturus Therapeutics$12.89+1.9%2.8033 of 5 stars3.13$59.20 359.3%80.36%ALLOAllogene Therapeutics$1.57-2.5%2.964 of 5 stars2.90$9.29 491.6%10News Coverage0.36%ORICORIC Pharmaceuticals$5.19+0.4%3.3893 of 5 stars3.00$18.86 263.3%9News CoveragePositive News0.35%OABIOmniAb$1.82-1.6%2.3495 of 5 stars3.00$7.00 284.6%30.35%DNAGinkgo Bioworks$7.89+3.8%0.6178 of 5 stars1.60$4.58 -42.0%50.31%CRSPCRISPR Therapeutics$39.11+1.5%2.9725 of 5 stars2.48$73.11 86.9%210.23%SGMOSangamo Therapeutics$0.81+8.1%2.0525 of 5 stars2.67$5.17 534.0%60.22%CRGXCARGO Therapeutics$4.53-0.4%2.9534 of 5 stars1.86$15.00 231.1%7Positive News0.21%LGNDLigand Pharmaceuticals$108.55+2.6%4.3479 of 5 stars3.00$146.43 34.9%7News Coverage0.19%FDMT4D Molecular Therapeutics$3.25-5.0%2.8171 of 5 stars2.50$26.71 722.0%8Positive News0.13%BEAMBeam Therapeutics$20.17+1.5%2.7925 of 5 stars3.00$49.45 145.2%14Options Volume This page (NYSEARCA:IDNA) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Collapse Is Already HereWhen a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IDNA Stock Free IDNA Stock Alerts